home

research and development

transmucosal drug delivery

consumer market research
technology

 
  Transmucosal Drug Delivery (OraDisc™)  
 

Consumer Market Research:

 
     
 

In excess of 700 patients enrolled in a Phase III clinical study and a 28 day safety study completed a survey questionnaire:

 
 
  • Product considered easy to apply.
  • Perceived effectiveness scored highly.
  • Intent to purchase scored highly.
 
 

Independent consumer research has confirmed findings of the survey conducted on the clinical study patients.

 
     
     
     
     
     
     
     
     
     
     

 

 

© 2011 ULURU Inc.

Latest News
ULURU Inc. developed and commercializes Altrazeal®, a transforming powder dressing with proprietary Nanoflex® technology, for the management of exuding wounds.
Visit
www.altrazeal.com
for clinical case studies, patient testimonials, application guidelines, and much more…